Stocks / Stock overview

Clorox Co /de/ (CLX)

$102.53-1.06%Aft $102.46 (-0.07%)Market cap $12.40B

NYSE · Price as of · Nasdaq Real Time Price

Stock Scorer
Scoring…
Analyst consensus
Hold$101.65
  • Analysts17
  • Implied upside-0.9%
  • Target range$77.00 to $154.00
Analyst estimates are opinions, not forecasts of what the stock will do.
Source: Yahoo Finance consensus, retrieved
Next earnings
November 3, 2026in 66 days
  • EPS expected$1.11 +31%
  • A year ago$0.85
  • Revenue expected$1.88B +31%
  • Estimate range$0.88 to $1.20
Consensus of 15 analysts for the quarter ending September 30, 2026. Beat the estimate in 3 of the last four quarters. Estimates are what Wall Street expects, not our forecast.
Source: Yahoo Finance earnings calendar

SEC filings

Source: SEC EDGARLatest filed

FormFiledDescription
10-KAugust 7, 202610-K
8-KAugust 3, 20268-K
4July 24, 2026View on EDGAR
4July 17, 2026View on EDGAR
4July 2, 2026View on EDGAR
4July 2, 2026View on EDGAR
4July 2, 2026View on EDGAR
4July 2, 2026View on EDGAR
All SEC filings

Frequently asked questions

When does CLX report earnings?

Clorox Co /de/ (CLX) is scheduled to report quarterly results on November 3, 2026. The 15-analyst consensus is $1.11 per share on revenue of $1.88B for the quarter ending September 30, 2026, against $0.85 and $1.43B a year earlier. It has beaten the consensus EPS estimate in 3 of the last four quarters.

What do analysts expect for CLX?

17 analysts cover Clorox Co /de/ (CLX). The consensus rating is Hold. The average price target is $101.65, in a range of $77.00 to $154.00.

Are insiders buying or selling CLX?

We have no qualifying Form 4 insider purchases or sales on record for Clorox Co /de/ (CLX). Sales are only tracked above a dollar threshold, so small routine trades may not appear.

Where can I see CLX SEC filings?

Recent filings are listed on this page, newest first. The latest is a 10-K filed August 7, 2026.

Data on this page comes from SEC EDGAR, public disclosure feeds and market data providers, and may be delayed or incomplete. Nothing here is investment advice.